10,533 results on '"L. Havé"'
Search Results
2. Documenting the Full Value of Vaccination: A Systematic Review of Value Frameworks
3. Generative Artificial Intelligence for Health Technology Assessment: Opportunities, Challenges, and Policy Considerations: An ISPOR Working Group Report
4. Development and Valuation of a Preference-Weighted Measure in Age-Related Macular Degeneration From the Vision Impairment in Low Luminance Questionnaire: A MACUSTAR Report
5. Enhancing Patient Response to Patient-Reported Outcome Measures: Insights From a Leading Dutch University Hospital
6. Cost-Effectiveness of Hepatocellular Carcinoma Surveillance Strategies in Patients With Compensated Liver Cirrhosis in the United Kingdom
7. Discriminatory Properties of the Quality-Adjusted Life Year Based Cost-Effectiveness Analyses for Patients With Disabilities: A Duchenne Muscular Dystrophy Case Study
8. Remote-Use Applications of the Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised Clinical Outcome Assessment Tool: A Scoping Review
9. Qualitative and Psychometric Evaluation of 29-Item Patient-Reported Outcomes Measurement Information System® to Assess General Health-Related Quality of Life in Patients With Moderately to Severely Active Inflammatory Bowel Disease
10. Implementing Multilevel Network Meta-Regression for Time-To-Event Outcomes: A Case Study in Relapsed Refractory Multiple Myeloma
11. Cost-Effectiveness of Axicabtagene Ciloleucel for Adult Patients With Relapsed or Refractory Follicular Lymphoma in the United States
12. Development of a Value Assessment Framework for Pediatric Health Technologies Using Multicriteria Decision Analysis: Expanding the Value Lens for Funding Decision Making
13. Methods to Include Environmental Impacts in Health Economic Evaluations and Health Technology Assessments: A Scoping Review
14. Estimating a Minimal Important Difference for the EQ-5D-5L Utility Index in Dialysis Patients
15. Identifying the Optimum Strategy for Identifying Adults and Children With Celiac Disease: A Cost-Effectiveness and Value of Information Analysis
16. Cost-Effectiveness of Oral Nirmatrelvir/Ritonavir in Patients at High Risk for Progression to Severe COVID-19 in the United States
17. Establishing Meaningful Change Thresholds in Patient-Reported Outcomes Among Patients With Anaplastic Lymphoma Kinase-Positive Non–Small Cell Lung Cancer in ALTA-1L Trial
18. Patient Preferences in Pulmonary Arterial Hypertension, a Latent Class Analysis to Identify Preference Heterogeneity
19. IPECAD Modeling Workshop 2023 Cross-Comparison Challenge on Cost-Effectiveness Models in Alzheimer’s Disease
20. New International Pharmaco-Economic Collaboration on Alzheimer's Disease (IPECAD) Open-Source Model Framework for the Health Technology Assessment of Early Alzheimer’s Disease Treatment: Development and Use Cases
21. Effectiveness of Pneumococcal Vaccines on Otitis Media in Children: A Systematic Review
22. Economic Evaluations of Remote Patient Monitoring for Chronic Disease: A Systematic Review
23. Perspectives on Patient-Reported Outcome Data After Treatment Discontinuation in Cancer Clinical Trials
24. US Residents’ Preferences for Sharing of Electronic Health Record and Genetic Information: A Discrete Choice Experiment
25. Health Utility Analysis of Tepotinib in Patients With Non-Small Cell Lung Cancer Harboring MET Exon 14 Skipping
26. Best Practice Recommendations for Electronic Patient-Reported Outcome Dataset Structure and Standardization to Support Drug Development
27. Mapping Oswestry Disability Index Responses to EQ-5D-3L Utility Values: Are Cost-Utility Results Valid?
28. Economic Evaluation of Family-Focused Programs When Parents Have a Mental Health Problem: Methodological Considerations
29. Caregiving-Related Work Productivity Loss Among Employed Family and Other Unpaid Caregivers of Older Adults
30. Development of the Cystic Fibrosis Questionnaire-Revised-8 Dimensions: Estimating Utilities From the Cystic Fibrosis Questionnaire-Revised
31. Suitability of Preference Methods Across the Medical Product Lifecycle: A Multicriteria Decision Analysis
32. Cost-Effectiveness of Respiratory Syncytial Virus Preventive Interventions in Children: A Model Comparison Study
33. The Zero-Price Conundrum: Exploration of Scenarios Where a Clinically Effective New Drug Might Not Be Cost-Effective at Zero Price
34. Cost-Effectiveness Analysis of Vaccination With Recombinant Zoster Vaccine Among Hematopoietic Cell Transplant Recipients and Persons With Other Immunocompromising Conditions Aged 19 to 49 Years
35. A Guide to Selecting Flexible Survival Models to Inform Economic Evaluations of Cancer Immunotherapies
36. Preferences for Sexually Transmitted Infection and Cancer Vaccines in the United States and in China
37. Developing Patient-Centered Real-World Evidence: Emerging Methods Recommendations From a Consensus Process
38. Patient Expectations About Palliative Treatment for Symptomatic Spinal Metastases: A Qualitative Study
39. A Cost-Effectiveness Framework for Amyotrophic Lateral Sclerosis, Applied to Riluzole
40. No Time to Waste: An Appraisal of Value at the End of Life
41. HARmonized Protocol Template to Enhance Reproducibility of Hypothesis Evaluating Real-World Evidence Studies on Treatment Effects: A Good Practices Report of a Joint ISPE/ISPOR Task Force
42. Defining Patient Engagement in Research: Results of a Systematic Review and Analysis: Report of the ISPOR Patient-Centered Special Interest Group
43. Quantifying Downstream Healthcare Utilization in Studies of Genomic Testing
44. Validating Restricted Mean Survival Time Estimates From Reconstructed Kaplan-Meier Data Against Original Trial Individual Patient Data From Trials Conducted by the Canadian Cancer Trials Group
45. A Comparison of a Preliminary Version of the EQ-HWB Short and the 5-Level Version EQ-5D
46. Developing a New Generic Health and Wellbeing Measure: Psychometric Survey Results for the EQ-HWB
47. Variation in Model-Based Economic Evaluations of Low-Dose Computed Tomography Screening for Lung Cancer: A Methodological Review
48. Opportunities and Barriers to the Development and Use of Open Source Health Economic Models: A Survey
49. A Framework for Using Real-World Data and Health Outcomes Modeling to Evaluate Machine Learning–Based Risk Prediction Models
50. Assessing Payers’ Preferences for Real-World Evidence in the United States: A Discrete Choice Experiment
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.